Torres Filho IP, Torres LN, Salgado C, Dubick MA. Plasma syndecan-1 and heparan sulfate correlate with microvascular glycocalyx degradation in hemorrhaged rats after different resuscitation fluids. Am J Physiol Heart Circ Physiol 310: H1468 -H1478, 2016. First published April 1, 2016; doi:10.1152/ajpheart.00006.2016.-The endothelial glycocalyx plays an essential role in many physiological functions and is damaged after hemorrhage. Fluid resuscitation may further change the glycocalyx after an initial hemorrhage-induced degradation. Plasma levels of syndecan-1 and heparan sulfate have been used as indirect markers for glycocalyx degradation, but the extent to which these measures are representative of the events in the microcirculation is unknown. Using hemorrhage and a wide range of resuscitation fluids, we studied quantitatively the relationship between plasma biomarkers and changes in microvascular parameters, including glycocalyx thickness. Rats were bled 40% of total blood volume and resuscitated with seven different fluids (fresh whole blood, blood products, and crystalloids). Intravital microscopy was used to estimate glycocalyx thickness in Ͼ270 postcapillary venules from 58 cremaster preparations in 9 animal groups; other microvascular parameters were measured using noninvasive techniques. Systemic physiological parameters and blood chemistry were simultaneously collected. Changes in glycocalyx thickness were negatively correlated with changes in plasma levels of syndecan-1 (r ϭ Ϫ0.937) and heparan sulfate (r ϭ Ϫ0.864). Changes in microvascular permeability were positively correlated with changes in both plasma biomarkers (r ϭ 0.8, P Ͻ 0.05). Syndecan-1 and heparan sulfate were also positively correlated (r ϭ 0.7, P Ͻ 0.05). Except for diameter and permeability, changes in local microcirculatory parameters (red blood cell velocity, blood flow, and wall shear rate) did not correlate with plasma biomarkers or glycocalyx thickness changes. This work provides a quantitative framework supporting plasma syndecan-1 and heparan sulfate as valuable clinical biomarkers of glycocalyx shedding that may be useful in guiding resuscitation strategies following hemorrhage.
THE DYNAMIC EQUILIBRIUM of the vascular system, observed under physiological conditions, is profoundly disturbed after hemorrhage and trauma. Even after partial or complete restoration of the lost blood volume via fluid resuscitation, the system may remain dysfunctional to some degree. The tissue damages induced by hemorrhage and trauma are complex and not well understood. Similarly, the iatrogenic and therapeutic mechanisms of several resuscitative agents are uncertain (39) . It is clear, however, that the microcirculation plays a major role in hemorrhage, trauma, and resuscitation (39, 66) .
Recently, endothelial dysfunction has emerged as a critical component associated with hemorrhagic shock and trauma (27) . The endothelial glycocalyx, an integral component of the endothelial barrier, is composed of membrane-spanning backbone molecules of proteoglycans (syndecans and glypican-1), with associated side-chain molecules made of glycosaminoglycans (heparan sulfate, chondroitin sulfate, and hyaluronan), and glycoproteins that are membrane-bound (12, 19, 65) . The endothelial glycocalyx plays an essential role in many physiological functions such as lipid homeostasis regulation, permeability, inflammation, coagulation, and mechanotransduction of shear stress, leading to changes in local blood flow (19, 41, 43) .
Glycocalyx degradation is correlated with diabetes (42), sepsis (14) , trauma (30) , hypoxia (5, 7, 64) , and ischemia (5, 36, 46, 48, 53) in humans and animals. Previously, using intravital microscopy, we (57) showed that microvascular glycocalyx thickness was reduced after hemorrhage in skeletal muscle and mesenteric venules. Using electron microscopy images of venules, Kozar et al. (32) reported similar data in a more severe model of hemorrhagic shock. Different studies suggested at least partial recovery of the damaged glycocalyx by treatment with plasma and other blood-derived resuscitation fluids, but not by treatment with crystalloids (32, 59, 60) . These data suggested that fluid resuscitation could prompt further changes in the glycocalyx after an initial hemorrhage-induced degradation.
Syndecan-1 and heparan sulfate levels can be readily determined in plasma samples and have been used as indirect markers of glycocalyx degradation. Since direct measures of glycocalyx thickness are technically challenging or impractical in clinical settings, these biomarkers have been frequently reported in human studies (22, 24, 26) . Sometimes, only syndecan-1 is reported (30, 52) . However, the extent to which measures of these biomarkers are representative of the events at the microcirculation following hemorrhage and resuscitation is unknown. To fill this gap, it is important to quantitatively address the relationship between plasma biomarkers of glycocalyx degradation and changes in various microvascular physiological parameters, including glycocalyx thickness.
We hypothesized that hemorrhage and the several resuscitation fluids currently in use act on the cardiovascular system by different mechanisms, hence offering an opportunity to study a wide range of changes in glycocalyx and microhemodynamics. Therefore, an extensive series of experiments was conducted using hemorrhage and resuscitation with multiple fluids, measurements of venular glycocalyx thickness and microhemodynamics using intravital video microscopy, simultaneous monitoring of systemic parameters, and blood sampling. We then assessed the correlation between various local microvascular parameters and different plasma biomarkers of glycocalyx shedding, providing insights into the glycocalyx pathophysiology after hemorrhage and resuscitation.
MATERIALS AND METHODS
All protocols were approved by the Institutional Animal Care and Use Committee of the US Army Institute of Surgical Research. This study was conducted in compliance with the Animal Welfare Act, the implementing Animal Welfare Regulations, and the National Institutes of Health guidelines for the care and use of laboratory animals.
Fifty-eight male Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA; 226 Ϯ 4 g body mass) breathing spontaneously 100% O 2 were anesthetized with isoflurane (2%) and then tracheostomized to ensure a patent airway.
Systemic measurements. One carotid artery was cannulated for monitoring blood pressure. One femoral vein was used for infusion of fluorescent dyes and other fluids, and one femoral artery was used for blood withdrawal and collection of blood samples. Total hemoglobin concentration, pH, lactate, base excess, bicarbonate, and K ϩ were measured from blood samples (CG4, CHEM8 modules, I-stat, Abbott, Chicago, IL). Blood was collected for hematocrit measurement (microhematocrit centrifuge model MB, International Equipment Company, Needham Heights, MA). Hemoglobin O 2 saturation (SO2) and respiratory rate (RR) were measured noninvasively (MouseOx, Starr Lifesciences, Oakmont, PA). Arterial blood pressure, heart rate, core temperature, SO 2, and RR were monitored and continuously recorded using an acquisition system (MP150, Biopac Systems, Goleta, CA) that also calculated the mean arterial blood pressure (MAP).
Intravital microscopy. The intravital microscopy system is described elsewhere (54) . It included a microscope (model BX51WI, Olympus), an immersion objective (Olympus ϫ60, numerical aperture 1.00), a tungsten-halogen lamp for transillumination, a metalhalide bulb for epi-illumination, and selective filter block systems for Texas Red (TR) and fluorescein isothiocyanate (FITC) fluorescence. One optical exit of the microscope was connected to a red blood cell (RBC) velocity-measuring device (optical Doppler velocimeter, Texas A & M University), a color camera (KP-D531U-S3, Hitachi, Tokyo, Japan), and a video monitor. The second exit was connected to a digital charge-coupled device camera (CoolSNAP cf, Roper Scientific, Trenton, NJ) with 1,392 ϫ 1,040-pixel resolution. The images were digitally stored for later analysis. Volumetric microvascular blood flow was determined using the mean RBC velocity and the vessel cross-sectional area ( ϫ diameter 2 /4), assuming a circular cross section (58) . The wall shear rate was calculated as 8 ϫ mean RBC velocity Ϭ vessel diameter, assuming a parabolic blood flow profile (58) .
Experimental animal preparation. The cremaster muscle was exteriorized and positioned flat over a thermostatically controlled pedestal (54) . During surgery, the muscle was bathed by a warm KrebsHenseleit solution. After exposure, the preparation was covered with a thin impermeable plastic film to minimize dehydration and gas exchange with the atmosphere. The animal platform was then positioned over the microscope stage.
Fluorescently labeled dextran solutions. Dextrans (Dx) of different molecular weights [Dx70 (70 kDa) and Dx500 (500 kDa)], labeled with TR or FITC, were used to measure the space occupied by the glycocalyx (54) . At baseline, TR-Dx70 (10 mg/ml; Molecular Probes) was injected for determination of the intact glycocalyx thickness, and FITC-Dx500 (10 mg/ml; Sigma) was injected after hemorrhageresuscitation (see below).
Fresh whole blood, packed RBC, and fresh frozen plasma preparations. Fresh whole blood (FWB) from the carotid artery of donor rats was collected in sterile syringes with 3.2% citrate (Baxter Healthcare, Deerfield, IL), stored at 4°C, and used within 24 h. Packed RBC (PRBC) units were prepared from whole blood from donor rats as previously described (59) and used within 48 h. Fresh frozen plasma (FFP), defined as plasma frozen within 6 -8 h of collection and stored at Ϫ80°C or lower for up to 1 yr (according to the American Association of Blood Banks), was prepared by separation also from whole blood from donor rats and collected in sterile syringes with 3.2% citrate (60) .
Experimental protocol. The experimental protocol is shown in Fig.  1 . Initially, three to six microscopic fields containing postcapillary venules were randomly selected. At 5 min before baseline measurements, TR-Dx70 was injected. Each field was recorded under transmitted light before epi-fluorescence illumination. Paired images of individual microvascular segments using each tracer were recorded using the charge-coupled device camera and transferred to a computer. Precautions were taken to minimize light exposure and excessive or undesirable probe excitation in studied and adjacent microvessels (54) .
We used a fixed-volume hemorrhage protocol that produces a hemorrhagic shock model where the MAP is not kept at any predetermined level (56) . The hemorrhage was induced in 30 min, using , dose 75 ml/kg), 7) resuscitation with a 3% (hypertonic) solution of sodium chloride (HTS; rate 1.5 ml·kg Ϫ1 ·min Ϫ1 , dose 8 ml/kg), and 8) resuscitation with normal saline (NS; rate 1.5 ml·kg Ϫ1 ·min Ϫ1 , dose 45 ml/kg). At 1 h after the onset of resuscitation, FITC-Dx500 was injected, and paired recordings of the selected fields were performed. The first set of systemic parameters was collected during baseline, coinciding with the microcirculatory data. The final set of systemic measurements was performed 30 min after the end of resuscitation, also coinciding with the collection of microcirculatory data (120 min). Control animals (Sham) were subjected to all procedures except hemorrhage and resuscitation. All animals that survived the complete protocol were euthanized while under anesthesia at the end of the experimental period.
Glycocalyx thickness measurements. Glycocalyx thickness was measured using a technique described by us (54) based on the dye-exclusion method (25) and on a digital analysis process (20) . Briefly, epi-and transillumination images collected in vivo were used to measure the width of the fluorescent column and the microvessel anatomic diameter. A measurement line was traced perpendicular to the longitudinal axis of each vessel, and a profile of the light intensity was produced along this line. This profile helped us determine the anatomic diameter and the inflection points in the dye intensity curves, taken as the outer edges of the glycocalyx. Images were processed and measurements were obtained off-line (Image-Pro Plus, MediaCybernetics) using a high-resolution monitor (model U3011, Dell; 2,560 ϫ 1,600-pixel resolution) at a final magnification of approximately ϫ2,500 (54). The distance scale was calibrated by recording the image of a stage micrometer. The scaling factor was 0.065 m/pixel.
Permeability index measurements. Microvascular permeability to FITC-labeled bovine serum albumin (FITC-BSA, 20 mg/ml; SigmaAldrich, St. Louis, MO) was estimated as previously described (13). Briefly, image-processing software was used to assess fluorescence leaks in selected vessels after injection of FITC-BSA. Quantification was performed off-line (ImageJ software, National Institutes of Health, Bethesda, MD) by measurement of the fluorescence intensity of six areas within the venules (I v) and in the perivenular interstitium (Ip). The permeability index (PI) was calculated as the ratio of Ip to Iv.
Plasma levels of syndecan-1 and heparan sulfate proteoglycan. FFP (stored at Ϫ80°C) was thawed and used to analyze rat syndecan-1 and cell surface/extracellular matrix heparan sulfate proteoglycan using commercial enzyme-linked immunoabsorbent assay (ELISA) kits (catalog nos. ABIN416453 and ABIN416454, respectively, Antibodies Online, Atlanta, GA) according to the manufacturer's instructions.
Data analysis, presentation, and statistics. In most cases, changes in various parameters are expressed as a ratio of postresuscitation to baseline measurements. The deviation from Gaussian distribution was tested for all systemic and microvascular data using the Shapiro-Wilk test. Parametric tests were found adequate. Values are means Ϯ SE. Differences between before and after resuscitation for each group were analyzed using paired t-test. Experiments in each group were conducted at separate times. For correlation analysis, linear leastsquares regressions were performed, and significance of the correlation coefficients (r) was tested. For technical reasons, it was not possible to obtain measurements of all parameters from all animals and microvessels of the nine animal groups. Therefore, different correlations used data subsets of different sizes. The statistical tests were performed using commercial computer software (SigmaPlot 12.0, Systat Software, San Jose, CA, and Excel 2010, Microsoft). All P values correspond to two-tailed tests, with significance set at 0.05.
RESULTS
Systemic responses. Animals subjected to all procedures except hemorrhage and resuscitation (Sham group) showed relatively stable systemic parameters throughout the 3-h experimental period (data not shown). In the remaining animal groups, hemorrhaged animals were bled an average of 23.9 Ϯ 0.1 ml/kg. As expected, untreated shocked (HEM) animals showed the most severely affected systemic parameters. Approximately 90% of rats from all groups survived the complete protocol. The systemic responses to hemorrhage in this model are described elsewhere (54, 59, 60) . Furthermore, pooled data from 19 sample animals of different groups confirmed that hemorrhage reduced baseline MAP from 100.1 Ϯ 1.7 to 49.7 Ϯ 3.0 mmHg. Similarly, hemorrhage increased baseline shock index and K ϩ and lactate levels from 3.0 Ϯ 0.2, 4.1 Ϯ 0.3 mmol/l, and 1.3 Ϯ 0.5 mmol/l to 4.3 Ϯ 0.3, 5.5 Ϯ 0.5 mmol/l, and 5.6 Ϯ 3.8 mmol/l, respectively. Changes in relevant systemic parameters before and after resuscitation are presented in Fig. 2 . Animals receiving blood or blood-derived products showed the best overall recovery, with the lowest levels of shock index, lactate, and K ϩ and the highest levels of base excess and MAP. Hemodilution, leading to significantly lower hematocrit in all groups after resuscitation than at baseline, was commonly observed. RR was not different among animal groups during baseline and averaged 71 Ϯ 9 min Ϫ1 . After hemorrhageresuscitation, RR values were also similar and averaged 79 Ϯ 8 min
Ϫ1
. Since animals were breathing 100% O 2 , arterial PO 2 and SO 2 remained above 300 mmHg and 99%, respectively, throughout the experiment.
Plasma levels of syndecan-1 and heparan sulfate proteoglycan. FFP from 8 control rats and 46 hemorrhaged animals subjected to 7 resuscitation fluids were used to analyze the relationship between the plasma levels of heparan sulfate and syndecan-1 proteoglycans (Fig. 3) . A statistically significant positive linear relationship was found. Baseline levels of these biomarkers were not different among animal groups (Table 1) .
Microvascular responses. A total of 272 postcapillary venules from 58 cremaster preparations were studied in 9 animal groups (average of 6 rats per group, 5 venules per rat). Microvascular diameter, blood flow, wall shear rate, and in vivo glycocalyx thickness were determined using RBC velocity measurements as well as images collected before hemorrhage and after resuscitation. Baseline venular diameter, blood flow, wall shear rate, and glycocalyx thickness were not different among animal groups, averaging 15.7 Ϯ 0.3 m, 0.2 Ϯ 0.1 nl/s, 315 Ϯ 13 s Ϫ1 , and 0.543 Ϯ 0.015 m, respectively ( Table 1) . Exposure of animals to hemorrhage and different resuscitation fluids resulted in various levels of glycocalyx degradation, as expressed by different levels of glycocalyx thickness and plasma concentrations of syndecan-1 and heparan sulfate. Table 2 for details of the regression). N, number of animal groups; r, correlation coefficient. See Fig. 2 legend for descriptions of animal groups. Values are means Ϯ SE; n, number of measurements.
Glycocalyx thickness and plasma biomarkers. Figure 4 depicts changes in glycocalyx thickness and two plasma biomarkers of glycocalyx shedding (syndecan-1 and heparan sulfate) after hemorrhage and seven different resuscitation treatments. In vivo measured changes in glycocalyx thickness showed a strong and statistically significant negative correlation with both plasma biomarkers (r ϭ 0.9, P Ͻ 0.01). Figure 5 shows the relationship between changes in microvascular permeability and plasma levels of syndecan-1 and heparan sulfate after hemorrhage and six different resuscitation treatments. A statistically significant positive correlation with both plasma biomarkers was also found. In both cases (glycocalyx thickness and permeability), animals treated with blood or blood-derived products showed the smallest microvascular changes and the smallest changes in plasma levels of biomarkers, whereas animals receiving crystalloids showed the largest changes. Except for a significant correlation between changes in microvascular diameter and syndecan-1, changes in plasma biomarkers after hemorrhage-resuscitation were not correlated with changes in venular microhemodynamic parameters such as RBC velocity, blood flow, or wall shear rate (Table 2) .
Glycocalyx thickness and microvascular parameters. We also investigated the relationship between in vivo measure- Fig. 4 . A: postresuscitation change in glycocalyx thickness and plasma syndecan-1 for each animal group. Data were obtained using 275 microvessels and 58 animals divided into 9 groups (average 6 rats/group and 5 vessels/ preparation). B: postresuscitation change in glycocalyx thickness and plasma heparan sulfate for each animal group. Data were obtained using 137 microvessels and 27 animals divided into 8 groups (average of 3 rats/group and 5 vessels/preparation). Data are expressed as described in Fig. 3 legend. See Fig.  2 legend for descriptions of animal groups. Fig. 5 . A: postresuscitation change in microvascular permeability and plasma syndecan-1 for each animal group. Data were obtained using 166 microvessels and 37 animals divided into 8 groups (average 5 rats/group and 4 vessels/ preparation). B: postresuscitation change in microvascular permeability and plasma heparan sulfate for each animal group. Data were obtained using 100 microvessels and 22 animals divided into 7 groups (average 3 rats/group and 5 vessels/preparation). Data are expressed as described in Fig. 3 legend. See Fig. 2 legend for descriptions of animal groups. ments of glycocalyx thickness and various microvascular parameters (Table 2 ). Figure 6 shows that microvascular permeability was also correlated with glycocalyx thickness measured in vivo, as well as two plasma biomarkers. Figure 6 also illustrates that the ALB group responded somewhat differently from the others. Although the permeability showed a good recovery (similar to FFP and Sham groups), the change in glycocalyx thickness remained at a low level, placing the mean for the group relatively far from the regression line. In fact, excluding the ALB group improves the correlation from r ϭ Ϫ0.754 (P ϭ 0.031) to r ϭ Ϫ0.812 (P ϭ 0.026).
Except for a significant correlation with changes in microvascular diameter (Fig. 7) , changes in glycocalyx thickness after hemorrhage-resuscitation did not correlate with changes in venular microhemodynamic parameters such as RBC velocity, blood flow, or wall shear rate (Table 1) .
DISCUSSION
In the present studies, subjecting animals to hemorrhage and a wide range of resuscitation fluids resulted in various levels of glycocalyx degradation, as expressed by different levels of glycocalyx thickness and plasma concentrations of syndecan-1 and heparan sulfate. To our knowledge, this is the first study of the quantitative relationships between these plasma biomarkers and changes in microvascular parameters, including glycocalyx thickness. Previous studies of microvascular stabilization following hemorrhagic shock utilized few resuscitation fluids (63) , or glycocalyx measurements were not performed using intravital microscopy (32) . A positive correlation was also found between changes in plasma syndecan-1 and heparan sulfate. Similar results were previously reported for measurements of these biomarkers after ischemia-reperfusion in humans (46) . However, we found that both plasma biomarkers were poor indicators of microhemodynamic alterations occurring simultaneously in the venules during hemorrhage and fluid resuscitation.
While the administration of resuscitation fluids is a clear therapeutic option after major blood losses, different fluids produce varying degrees of magnitude and duration of intravascular volume expansion (21) . Moreover, they may have a complex impact on the physiology of the microcirculation, which may affect tissue survival and, ultimately, outcome (3, 55, 61, 63) . However, the dynamics of the interactions between the resuscitation fluids and the glycocalyx have been relatively poorly studied. A meta-analysis of hemodilution studies showed that the parameter most strongly correlated with the vascular resistance was the dilution fluid (45) . The hypothesis was that solutions used in hemodilution experiments removed adsorbed proteins in the glycocalyx. Indeed, protein-free solutions lead to glycocalyx degradation as indicated by data from this work and previous evidence from our group and others (17, 60) .
Glycocalyx degradation. Using several treatment groups, we found a linear relationship for glycocalyx thickness and both plasma biomarkers. Resuscitation with blood and blood-derived products returned microvascular and plasma levels to measurements similar to those obtained in Sham animals. Conversely, crystalloid resuscitation increased plasma concentrations of syndecan-1 up to five times the baseline level, reducing glycocalyx thickness up to 20% of its baseline level. Fig. 6 . Postresuscitation change in microvascular permeability and glycocalyx thickness for each animal group. Data were obtained using 164 microvessels and 37 animals divided into 8 groups (average 5 rats/group and 4 vessels/ preparation). Data are expressed as described in Fig. 3 legend. See Fig. 2 legend for description of animal groups. N, number of animal groups included in regression analysis; n, total number of venules where intravital microscopy measurements were performed; r, correlation coefficient. *Statistically significant.
The disruption of endothelial integrity by hemorrhagic shock leading to syndecan-1 shedding, observed in this work, has been reported previously (23) . Measurements of glycocalyx thickness in syndecan-1-deficient mice suggest that the lack of syndecan-1 may be compensated by the increase in expression of other proteoglycans. Therefore, syndecan-1 may not be a prerequisite for the existence of an endothelial glycocalyx (51) . Nevertheless, the correlations between glycocalyx thickness and plasma syndecan-1 or heparan sulfate levels have important clinical implications to monitor in studies of hemorrhagic shock and trauma resuscitation.
Previous work points toward a link between ischemia and glycocalyx degradation in heart (46), liver (62) , and mesentery (36) . Glycocalyx degradation was observed after crystalloid infusion in normovolemic humans (8, 9) and in hemorrhaged rats resuscitated with crystalloids (2). We measured glycocalyx reduction in untreated animals subjected to a nonlethal, relatively moderate model of hemorrhagic shock, confirming our previous reports that this level of hemorrhagic shock reduces glycocalyx thickness in mesenteric and cremasteric venules (57) .
If it is assumed that glycocalyx damage is systemic, the endothelial surface covered by the glycocalyx is large, and the glycocalyx is involved in various processes (65) including permeability (49) and mechanotransduction of fluid shear stress (65), the potential consequences of glycocalyx degradation are substantial. After ischemia and inflammation, glycocalyx shedding promotes neutrophil/leukocyte access to tissue (33, 38) , and a similar mechanism could be present during hemorrhage. However, most previous studies did not consider the glycocalyx pro-and antiadhesive functions that may affect blood cell-endothelium interactions (34) . Although all the mechanisms cited above were likely to be at work during our experiments, an integrated model of glycocalyx damage after hemorrhage-resuscitation is preliminary and incomplete. Figure 8 summarizes some of the mechanistic elements connecting hemorrhage, resuscitation fluids, and the endothelial glycocalyx in the present studies.
Glycocalyx restoration. This study provides the first direct comparison among many different resuscitation fluids of their ability to restore systemic parameters and the endothelial glycocalyx, as estimated by its thickness and by levels of two plasma biomarkers. Despite partial MAP recovery and, sometimes, even full recovery of lactate, most fluids did not provide the level of glycocalyx restoration achieved by blood and FFP. The protection or restoration of previously damaged glycocalyx has been considered a promising therapeutic target aimed to diminish oxygen radical stress (42) or to increase glycocalyx production or prevent proteolytic activity (15, 40) . Other alternatives used different compounds such as antithrombin (16) , sevoflurane (4), diazoxide (35) , and agglutinin lectin (50) .
On a few occasions, attempts to reconstitute the glycocalyx after its degradation have been verified in vivo using intravital microscopy. Doxycycline (37), hyaluronan and heparin (48) , and heparan sulfate and heparin (18) have been effective in restoring glycocalyx damage. Reconstitution of the surface matrix was also observed using hyaluronan premixed with chondroitin sulfate chains (25) . The current study provides in vivo evidence that whole blood and plasma can restore the glycocalyx after hemorrhage, probably through reconstitution of the surface matrix as described in the studies mentioned above. In our protocol, complete glycocalyx restoration occurred following infusion of smaller plasma volumes than previously reported (32) . The data support the concept of vascular stabilization by infused plasma (23) , in which glycocalyx recovery is an important component. The early use of FFP as a resuscitative agent has been associated with improved survival after hemorrhagic shock (11, 28, 31) . Rat FFP contains all known coagulation and anticoagulant proteins in concentrations found in normal rat blood. Therefore, in addition to its effects on the endothelium, the infused plasma may exert its positive effects by replacing lost coagulation factors, (re)-establishing hemostasis, and reversing coagulopathy (23) .
The glycocalyx structure includes plasma proteins (41) . Since this layer is in dynamic equilibrium with the flowing plasma (44), the thickness and composition of the glycocalyx depend on the plasma composition and the local hemodynamic conditions. We found the lowest level of glycocalyx thickness in NS and LR animals, while solutions containing proteins such as albumin could partially restore the glycocalyx. We hypothesize that, after hemorrhage-induced glycocalyx degradation, resuscitation with crystalloids will lead to further removal of adsorbed glycocalyx proteins, while resuscitation with protein-rich solutions will help reestablish the disturbed glycocalyx composition. Albumin is one of the primary carriers of the phospholipid sphingosine-1-phosphate (S1P). Zeng et al. (67) recently evaluated the hypothesis that S1P, acting via S1P1 receptors, could have a role in stabilizing the endothelial glycocalyx. Their results suggested that S1P plays a critical role in protecting the glycocalyx via S1P1 receptors and inhibits the protease activity-dependent shedding of heparan sulfate and the syndecan-1 ectodomain. However, our results suggest that the structural recovery provided by albumin was only partial, even though permeability was considerably restored (see below).
Glycocalyx monitoring. Current therapeutic interventions for the treatment of hemorrhagic shock are generally aimed at the restoration of systemic variables (3, 47) . However, the formulation and administration of artificial infusion fluids for therapeutic purposes should also avoid detrimental effects to the glycocalyx. As discussed above and as our data suggest, resuscitation fluids may restore or damage the glycocalyx. A new paradigm for the treatment of hemorrhage should aim at restoring or maintaining the glycocalyx structure and functional integrity. Monitoring these effects then becomes essential (14) . The endothelial glycocalyx has enormous, yet largely untapped, therapeutic potential (1, 43) . The quantitative relationships described in the current work may help the investigation and evaluation of the glycocalyx, not only as an indicator of the pathogenic process but also of the efficacy of therapies such as resuscitation fluids.
Permeability. Changes in microvascular permeability are observed during hemorrhagic shock (49) . Since all resuscitation fluids can contribute to edema formation (39) and the glycocalyx is critically involved in determining transvascular exchange after resuscitation (66), a multifluid comparison with regard to permeability is of great interest. Our data showed that changes in permeability were correlated with changes in both plasma biomarkers, as well as with changes in glycocalyx thickness. Therefore, these biomarkers were surrogate markers of the endothelial injury and its functional effect on permeability. Moreover, data from glycocalyx and permeability changes after albumin showed that while permeability had returned to values close to baseline, glycocalyx thickness remained reduced. These data suggest that the recovery of permeability after albumin may be due to other factors not related to a full structural reconstitution of the glycocalyx. Lower edema formation by albumin has also been reported (29) .
Advantages and limitations. One advantage of the current study design is that different levels of glycocalyx damage, rather than two post hoc categories ("hi" and "low" degradation) as used in some reports, could be achieved. In addition, all subjects and fluids were evaluated under the same protocol, and the same methodology was used to measure each parameter in all subjects. These circumstances are very difficult to achieve in clinical scenarios and currently technically impossible outside experimental settings. This study has several limitations. Since only one sample was collected after resuscitation, it was not possible to obtain information on the time course of the changes in glycocalyx thickness or to perform regressions between parameters within treatments. Values were normalized to the baseline, and only grouped averages were used for regressions. While this procedure allowed us to condense large amounts of data and revealed relationships among various parameters for many resuscitation fluids, it also damped the variability in responses and measurements. Therefore, the quantitative interpretation of the relationships should be viewed with caution, especially in weak correlations. Another limitation is the relatively small sample size in terms of number of animals per group. Nevertheless, because several Fig. 8 . Conceptual model including key elements connecting hemorrhagic shock and resuscitation fluids with the endothelial glycocalyx (EG), microcirculation, and some systemic parameters. Factors in filled blocks were directly measured in this study. Hemorrhage reduces arterial pressure, blood flow, and O2 delivery. Ischemia lowers shear stress on endothelial cell (EC) surface, decreasing nitric oxide (NO) production. Ischemia-reperfusion leads to oxidative stress. Reactive oxygen species formation and hypoxia may cause EG degradation. Depending on degradation severity, EG mechanosensing can be compromised or eliminated until the layer can repair itself. Damaged EG can increase leukocyte adhesion to venular EC, disrupt permeability, and cause edema, further increasing vascular resistance. Disruption of EG integrity elevates levels of plasma biomarkers (syndecan-1 and others) that also affect coagulation and hemostasis. Maintenance of the EG structure and function is therefore critical. Therapeutic strategies, including fluid resuscitation aimed at preventing or minimizing EG damage or restoring its integrity, will be beneficial in returning the tissues to a normal state.
groups were used to determine the significance of the relationships and a relatively large number of vessels were studied per group (average of 24), increased confidence in the results was obtained.
Despite the significant correlation between measures of glycocalyx thickness and plasma biomarkers of degradation, levels of plasma biomarkers should be viewed with caution. The interpretation of structural vascular changes, based on the plasma biomarkers' levels and/or their relationships, is more complex and may require additional information. Moreover, since syndecan-1 and heparan sulfate are also found on epithelial cells (10) , only when measures are made directly in the vessel can one be sure that the source was the endothelial glycocalyx. Recent evidence suggests that the epithelial barrier may be compromised during hemorrhage, leading to syndecan-1 shedding (6). Hence, plasma syndecan-1 levels may not be a unique marker of microvascular events. Furthermore, our data showed that changes in microhemodynamic parameters did not correlate with changes in plasma biomarkers. Therefore, direct local evaluation of the microvasculature remains important to assess critical parameters for tissue survival such as blood flow and precise measures of glycocalyx structure and function.
Conclusions. The experimental work supports an integrative approach of local and systemic physiological indexes leading to tissue viability (Fig. 8) . The data suggest that blood and plasma, but neither colloid resuscitation nor crystalloid resuscitation, support vascular stabilization by reconstitution of the endothelial glycocalyx after hemorrhage-mediated degradation. Concurrent measurements of microvascular diameter, blood flow, glycocalyx thickness, and plasma levels of glycocalyx shedding biomarkers, coupled with evaluation of systemic parameters after hemorrhage and resuscitation with different fluids, provide a quantitative framework describing glycocalyx degradation and recovery. The relationships defined in the current work offer the basis for use of glycocalyx degradation components as surrogate markers of endothelial injury that may help limit (or select) fluid resuscitation. Considering the protection or restoration of the glycocalyx as an important therapeutic goal, the quantitative framework provided here confirms that monitoring plasma syndecan-1 or heparan sulfate as biomarkers of glycocalyx shedding is valid and may be useful in guiding resuscitation strategies following hemorrhage. Whether this relationship would hold in other shock or trauma models requires further investigation.
